Affinia Therapeutics
OverviewSuggest Edit
Affinia Therapeutics is a biotech company. It develops transformative gene therapies for devastating diseases.
| Type | Private | |
| Founded | 2019 | |
| Website | affiniatx.com |
Latest Updates
| Employees (est.) (Oct 2020) | 30 | (+4%) |
| Cybersecurity rating | B | More |
Affinia Therapeutics Financials and Metrics
Summary Metrics
Founding Date | 2019 |
Affinia Therapeutics total Funding | $60 m |
Affinia Therapeutics latest funding size | $60 m |
Time since last funding | 7 months ago |
Affinia Therapeutics investors | New Enterprise Associates, Atlas Venture, Partners Innovation Fund, Lonza Group, Alexandria Venture Investments, F-Prime Capital |
Affinia Therapeutics's latest funding round in March 2020 was reported to be $60 m. In total, Affinia Therapeutics has raised $60 m
Affinia Therapeutics Cybersecurity Score
Affinia Therapeutics Online and Social Media Presence
Affinia Therapeutics's Trends
Affinia Therapeutics Frequently Asked Questions
When was Affinia Therapeutics founded?
Affinia Therapeutics was founded in 2019.
How many employees does Affinia Therapeutics have?
Affinia Therapeutics has 30 employees.
Who are Affinia Therapeutics competitors?
Competitors of Affinia Therapeutics include MicrofluidX, Stealth BioTherapeutics and CAMP4 Therapeutics.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies